Reborna Biosciences, Inc.
PrivateLast Round
VC Round
Jun 25, 2025
Total Funding Raised
$7.2M
Company Overview
Reborna Biosciences, Inc. is a biotechnology company that develops RNA-targeting small molecule drugs for the treatment of rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reborna Biosciences, Inc. Comparables
Compare Reborna Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| xFOREST Therapeutics Co., Ltd. | 87% | |
| Serna Bio | 85% | |
| Ribometrix | 83% | |
Reborna Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 25, 2025 | ||||
| Series D | May 25, 2023 | ||||
| Seed | Jun 25, 2018 |
Key People
Founding team and executive leadership
Reborna Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| THE GOGIN CAPITAL Co., Ltd. | VC Round |
| Angel Bridge | Series D, VC Round |
| Nissay Capital | VC Round, Series D |
| ICMG Group | VC Round |
| Mitsubishi UFJ Capital | Seed |
| Yokohama Capital Co., Ltd. | VC Round |
| UntroD Capital Japan Inc. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 67% MoM, reaching 1.8K.
- Jun 1, 2025
Monthly visitors grew 164% MoM, reaching 867.
Reborna Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reborna Biosciences, Inc.'s valuation, stock price, and market status.